Skip to main content

Table 1 Selected drugs and corresponding reference standards

From: A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country

Name of the drug, dose, dosage form

Reference document

Acetaminophen 500 mg/tab

MNP-2011,

NPM-0152-2014,

NPM-0046-2013

Acetylsalicylic acid, 81 mg/tab

BP-2013,

NPM-0114-2014

Amlodipine 10 mg/tab

NPM-0026-2013,

USP-36,

Registration document

Amoxicillin 500 mg/tab

BP-2013,

CP-2010,

MNP-2011,

Cefotaxime 1.0 g/powder for injection

BP-2013,

CP-2010,

NPM-42-0088298102,

NPM-0052-2013,

Registration document,

USP-36

Cetirizine 10 mg/tab

BP-2013,

CP-2010,

NPM-0224-2015,

Registration document,

USP-36

Ciprofloxacin 500 mg/tab

BP-2013,

CP-2010,

MNP-2011,

USP-36

Citramon-P (Acetylsalicylic acid+acetaminophen+caffeine), 450 mg /tab

MNP-2011,

NPM-0152-2014,

NPM-0154-2014

Diclofenac sodium 100 mg/tab

BP-2013,

CP-2010,

MNP-2011,

NPM-023-2015,

NPM-0270-2016,

NPM-0115-2014

Ibuprofen, 400 mg /tab

BP-2013,

BP-2015,

Registration document

Metronidazole 0.5%/100 ml infusion solution

CP-2010,

Registration document,

USP-36,

Nystatin 500,000 IU/tab

BP-2013,

USP-36,

Registration document

Omeprazole 20 mg/capsule

BP-2013,

Registration document

Panangin (Aspartic Acid, L- potassium and magnesium), 298 mg/tab

Registration document

Sildenafil citrate 100 mg/tab

NPM-0254-2016,

Registration document

  1. Note: BP British Pharmacopeia, CP Chinese Pharmacopeia, MNP Mongolian National Pharmacopeia, NPM National Pharmacopeial Monograph, USP United States Pharmacopeias